TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Skin thickness measured in millimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Measurement of histamine wheal by healthcare professional
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of NaCl wheal by healthcare professional
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of histamine wheal by digital device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of NaCl wheal by digital device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of documented FH diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving ≥35% Reduction in Spleen Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variations in HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resting and cycling stroke volume and function measured with echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in vascular conductance of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: safety and tolerability of ALE.F02
Endpoint domain: Adverse events/effects
Primary endpoint: Preparation for Decision Making (PrepDM) Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decisional Conflict: Ottawa Decision Support Framework (ODSF) scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Communication of preferences to doctor
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Clinician Administered PTSD Scale for DSM-5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot blood perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Foot and Ankle Ability Measure (FAAM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disablement in the Physical Active Scale (DPA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pain scores in patients with chronic wounds
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: quality of life in patients with chronic wounds
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence Percentage of Serious Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Appearance of fasciculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Levels of fasciculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Stress sensitivity (biological)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress sensitivity (psychological)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fear (biological)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear (psychological)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to Achieve First Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease remission of rheumatoid arthritis patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with sepsis at admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of deaths of enrolled patients
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Postoperative Nausea and Vomiting (PONV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Absence of Swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak systolic velocity of the clitoreal artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Pulsatility index of clitoreal artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Height of alveolar bone crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and type of dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: 5D Elman Itch Scale total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported dysphagia
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cumulative opioids consumption at 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hope, per Snyder's Hope Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of patients with worsening lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Intermetatarsal angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of the First Metatarsal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Electrocochleographic responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days to oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non nutritive suck patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in snacking frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in amount of added sugar consumption during snacking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in depression score at 6 weeks postpartum
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in anxiety score at 6 weeks postpartum
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful return to work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from baseline in weekly average of daily bladder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic Postural Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static Postural Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Knee Osteoarthritis Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Multi-Drug Resistant Tuberculosis (MDR-TB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean change in OSIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in happiness from baseline using the subjective happiness scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in valued life assessment from baseline using 4-item scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in depression from baseline using the CESD (8-item)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in anxiety from baseline using the HADS-A
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline fibrosis stage at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline steatosis stage at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in DFU size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraocular Pressure Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Prehospital recognition of stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Survival in cirrhosis and liver transplant patients
Endpoint domain: Mortality/survival
Primary endpoint: Incidence, nature, and severity of treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Integration of Xauron System into clinical workflow
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Degree of conditioned nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Inhibitory control in an emotional Go-Nogo task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxytocin release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: HPV vaccination rate per pharmacist at each pharmacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of pharmacy-based HPV vaccination: Pharmacy staff
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of pharmacy-based HPV vaccination: Pharmacy staff
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain during cervical instrumentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-years progression-free survival (FFS)
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in dyspigmentation at 12 weeks post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in dyspigmentation at 24 weeks post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ventilation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Success rate in ISGA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Consultation on Incontinence Questionnaire-short form score (ICIQ-SF)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in chewing ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Malnutrition Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Systolic blood pressure during daytime
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma nicotine delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute number and relative proportions of CD34+ cell subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dose-Limiting Toxicity (DLT) rate
Endpoint domain: Adverse events/effects
Primary endpoint: SLE Responder Index (SRI)-4 response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the patient's pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the patient's anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Negative Predictive Value (NPV) of HPV16 ct-DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: short-term postoperative pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Achieved Sustained Complete Remission (PDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Participants Who Achieved Sustained Complete Remission (ABSIS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Red Blood Cell Omega-3 Fatty Acid Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weekly measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in tear film break-up time (TFBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean difference in pain intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean difference in anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients achieving normal CAP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unscheduled hospitalization readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of CKD stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes from baseline Short Performance Physical Battery (SPPB) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil-to-lymphocyte ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative bioavailability of TLC590 compared to ropivacaine HCl injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose (MTD) of TLC590
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGA of clear (0) or almost clear (1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in carer emotional and relationship well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Average time to complete operations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: IL-6 concentration in pg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-8 concentration in pg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: TNF-α levels in pg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Periodontal pocket depth in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical attachment loss in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute stress disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bech 6-item subscale of the Hamilton Depression Rating Scale (HDRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in patient-reported clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale for Fatigue (VAS-F)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in rhythmically entrained eye-looking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-Form 12 (SF-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Joint Position Sense
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Motor function score at 18 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain score during the six-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pain score at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDPH incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Timeliness of receipt of opioids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Plasmatic measurement of 24S and 27 hydroxycholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasmatic measurement on total leukocytes of the level of complexes 1 to 5 associated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasmatic level of neurofilaments (SIMOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: average VAS score assessing subjects' eye dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severity of treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Microvascular/capillary blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Subjective Shoulder Stiffness (Visual Analogue Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: [11C]CURB binding in the brain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of controlled blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Supplement tolerability and acceptability
Endpoint domain: Adverse events/effects
Primary endpoint: Capillary beta-hydroxybutyrate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: elastic modulus values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to direct bilirubin > 2mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of EFAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative MRD conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corrected TIMI frame count (CTFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Forces applied to the epiglottis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Filtration efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self Reported 7 Day Abstinence Smoking Status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of ventilator- and vasopressor-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Agreement compared to Patient infected status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of patients virologically suppressed/undetectable at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competence of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of circulating ALDHhi primitive progenitor cells co-expressing CD133
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Breakpoint of Drug Purchase Task (DPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elasticity of Drug Purchase Task (DPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of Drug Purchase Task (DPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choice of anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: proportion of modified Rankin Scale (mRS) 0-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Montreal Cognitive Assessment Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Safety of CMV CTLs combined with anti-viral therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Response rates to treatment with CMV CTLs and anti-viral medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment (enrollment) rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cross-over frequencies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Malaria treatment outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Immunoglobulin G (IgG) anti-S antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-6, TNF-α, and IL-1ß
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: reactogenicity after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of manipulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Core outcome set for empty pelvis syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maxillary volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Intervention Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fidelity Score
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Viable BCG bacteria from intradermal challenge site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Identification of mesorectal microbial biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pathological evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100-day non-relapse mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Safety and tolerability of Descartes-08
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life focused on patients with constipation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The number of laxatives taken by each participant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: icECG ST-segment shift remission time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes